The 16th Annual European Congress of Rheumatology, organized by the European League Against Rheumatism (EULAR), provided the latest advances in the field of rheumatologic diseases to around 14,000 participants from more than 120 countries. This congress has become the primary platform for exchange of scientific and clinical information and the biggest rheumatology event in Europe. The congress covered a broad spectrum of the rheumatic diseases through 400 lectures, workshops, 300 oral presentations, 2,000 posters, 350 invited speakers, and basic science and clinical symposia.
Keywords: Blisibimod; CR-6086; Fosdagrocorat; INV-17; Namilumab; Nintedanib; SB-4; Tocilizumab; XmAb-5871.
Copyright 2015 Prous Science, S.A.U. or its licensors. All rights reserved.